American Cannabis Stock Beta
| AMMJ Stock | USD 0.0002 0.0001 33.33% |
American Cannabis fundamentals help investors to digest information that contributes to American Cannabis' financial success or failures. It also enables traders to predict the movement of American Pink Sheet. The fundamental analysis module provides a way to measure American Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to American Cannabis pink sheet.
American |
American Cannabis Company Beta Analysis
American Cannabis' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current American Cannabis Beta | 1.56 |
Most of American Cannabis' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, American Cannabis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, American Cannabis has a Beta of 1.5642. This is 14.18% higher than that of the Industrials sector and significantly higher than that of the Consulting Services industry. The beta for all United States stocks is notably lower than that of the firm.
American Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses American Cannabis' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of American Cannabis could also be used in its relative valuation, which is a method of valuing American Cannabis by comparing valuation metrics of similar companies.American Cannabis is currently under evaluation in beta category among its peers.
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, American Cannabis will likely underperform.
American Fundamentals
| Return On Equity | -0.93 | |||
| Return On Asset | -0.23 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.49 M | |||
| Shares Outstanding | 85.73 M | |||
| Shares Owned By Insiders | 25.49 % | |||
| Price To Earning | 62.93 X | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 2.43 M | |||
| Gross Profit | 1.06 M | |||
| EBITDA | (1.27 M) | |||
| Net Income | (1.44 M) | |||
| Cash And Equivalents | 873.76 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 806.73 K | |||
| Debt To Equity | 0.49 % | |||
| Current Ratio | 0.48 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (957.92 K) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 1.56 | |||
| Market Capitalization | 2.11 M | |||
| Total Asset | 4.22 M | |||
| Retained Earnings | (4.5 M) | |||
| Working Capital | (162 K) | |||
| Current Asset | 379 K | |||
| Current Liabilities | 541 K | |||
| Z Score | -0.2 | |||
| Net Asset | 4.22 M |
About American Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze American Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of American Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of American Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in American Pink Sheet
American Cannabis financial ratios help investors to determine whether American Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Cannabis security.